Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients
Tóm tắt
We aimed to report on the clinical findings and long-term prognosis of patients with cytomegalovirus (CMV) anterior uveitis. This was a retrospective observational study on 15 immunocompetent patients with CMV anterior uveitis and a follow-up longer than 24 months (mean: 62.1 ± 28.5 months). Uveitis was unilateral and hypertensive in all cases, with acute relapsing having the characteristics of Posner-Schlossman syndrome in nine (60 %) and chronic in nine patients (40 %), three of whom were clinically classified as Fuchs’ heterocromic iridocyclitis (20 %). All patients received topical antiviral and corticosteroid therapy, with six patients also receiving systemic therapy with valganciclovir or acyclovir. The mean number of uveitis relapses significantly decreased, before and after anti-CMV therapy, from 0.23 ± 0.17 to 0.03 ± 0.03 (p < 0.001), without significant differences among patients treated with topical therapy alone or combined topical and systemic therapy. Cataracts developed in nine out of 13 patients (69.2 %). A chronic raise in intraocular pressure (IOP) was found in 13 patients (86.6 %), with nine requiring surgery (60 %). At the end of the follow-up, all patients had a quiescent uveitis, with ten of them requiring topical low dose steroid therapy (66.6 %) and combined with systemic acyclovir in four cases. Eight patients (53.3 %) were on antiglaucomatous therapy. The last mean IOP value was 14.9 ± 3.6 mmHg (range 8–21 mmHg), and visual acuity was 0.89 ± 0.21. CMV-associated anterior uveitis has a fairly good long-term visual prognosis. Antiviral therapy can reduce the frequency of relapses, but cataracts and a chronic raise in IOP are frequent complications often requiring a surgical approach.
Tài liệu tham khảo
Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 50:1439–1447
Lepage N, Leroyer A, Cherot-Kornobis N, Lartigau I, Miczek S, Sobaszek A (2011) Cytomegalovirus seroprevalence in exposed and unexposed populations of hospital employees. Eur J Clin Microbiol Infect Dis 30(1):65–70
De Mattia D, Stroffolini T, Arista S, Pistoia D, Giammanco A, Maggio M, Chiaramonte M, Moschen ME, Mura I, Rigo G, Scarpa B (1991) Prevalence of cytomegalovirus infection in Italy. Epidemiol Infect 107(2):421–427
Markomickelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G (2002) Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy. Ophthalmology 109:879–882
van Boxtel LAA, van der Lelij A, van der Meer J, Los LI (2007) Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 114:1358–1362
de Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, LeHoang P, Davis JL, Bodaghi B (2006) Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. Br J Ophthalmol 90:852–855
Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH (2008) Clinical features of cytomegalovirus anterior Uveitis in immunocompetent patients. Am J Ophthalmol 145:834–840
Park SW, Yu HG (2013) Association of cytomegalovirus with idiopathic chronic anterior with ocular hypertension in Korean patients. Ocul Immunol Inflamm 21:192–196
Kongyai N, Sirirungsi W, Pathanapitoon K, Tananuvat N, Kunavisarut P, Leechanachai P, De Groot-Mijnes JD, Rothova A (2012) Viral causes of unexplained anterior uveitis in Thailand. Eye 26:529–534
Chee SP, Bacsal K, Jap A , Se-Thoe SY, Cheng CL, Tan BH (2007) Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 114:798–803
Alfawaz A (2013) Cytomegalovirus-related corneal endotheliitis: a review article. Saudi J Ophthalmol 27:47–49
Zamir E, Stawell R, Jhanjii V, Vajpayee RB (2011) Corneal endotheliitis triggered by cataract surgery in a Chinese patient with cytomegalovirus anterior uveitis. Clin Exp Ophthalmol 39:913–915
The standardization of uveitis nomenclature (SUN) working group (2005) Stadardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516
Bloch-Michel E, Dussaix E, Cerqueti P, Patarin D (1987) Possible role of cytomegalovirus infection in the etiology of Posner-Schlossman syndrome. Int Ophthalmol 11:95–96
Pivetti-Pezzi P, Accorinti M, La Cava M, Colabelli Gisoldi RAM, Abdulaziz MA (1996) Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 210:234–238
Sobolewska B, Deuter C, Doycheva D, Zierhut M (2014) Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol 252:117–124
Chee SP, Jap A (2010) Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol 94:1648–1652
Wong VW, Chan CK, Leung DY, Lai TY (2012) Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection. Clin Ophthalmol 6:595–600
Hwang YS, Lin KK, Lee JS, Chang SH, Chen KJ, Lai CC, Huang JC, Kuo YK, Hsiao CH (2010) Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis. Graefes Arch Clin Exp Ophthalmol 248:263–269
Miyanaga M, Sugita S, Shimizu N, Morio T, Miyata K, Maruyama K, Kinoshita S, Mochizuki M (2010) A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis. Br J Ophthalmol 94:336–340
Pavan-Langston D, Welch CL, Zegans ME (2012) Ganciclovir gel for cytomegalovirus keratouveitis. Ophthalmology 119:2411
The Herpetic Eye Disease Study Group (1998) Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 339:300–306
Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC (2013) Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (review). Cochrane Database Syst Rev. doi:10.1002/14651858, PMID: 23450543
Sira M, Murray PI (2007) Treatment of cytomegalovirus anterior uveitis with oral valaciclovir. Ocul Immunol Inflamm 15:31–32